American Century Companies’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Sell
257,924
-15,510
-6% -$563K ﹤0.01% 1541
2026
Q1
$8.33M Buy
273,434
+213,501
+356% +$7.05M ﹤0.01% 1541
2025
Q4
$2.15M Buy
59,933
+34,378
+135% +$1.05M ﹤0.01% 2062
2025
Q3
$616K Buy
+25,555
New +$535K ﹤0.01% 2452

Other funds holding INDV

American Century Companies's INDV Position: Q2 2026 in Review

American Century Companies reduced its Indivior Pharmaceuticals (INDV) stake by 5.7% in Q2 2026, selling an estimated $563K and leaving 257,924 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

American Century Companies first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 314 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • American Century Companies held 257,924 shares of Indivior Pharmaceuticals worth $10.6M as of Q2 2026.
  • American Century Companies sold 15,510 Indivior Pharmaceuticals shares in Q2 2026, an estimated $563K.
  • Indivior Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1541 holding.
  • American Century Companies first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 314 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.